Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.97
Z Squared Inc. entered into Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. valued at cash fee equal to 8.0% of the aggregate gross proceeds of the Private Placement, a management fee of (effective 2023-10-23).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Ladenburg Thalmann & Co. Inc.
- Value
- cash fee equal to 8.0% of the aggregate gross proceeds of the Private Placement, a management fee of
- Effective
- 2023-10-23
Exact text from the filing
Ladenburg Thalmann & Co. Inc. acted as the Company’s exclusive placement agent (the “Placement Agent”) in connection with the Private Placement, pursuant to that certain placement agency Agreement, dated October 23, 2023, by and between the Company and the Placement Agent (the “Placement Agency Agreement”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.98
Z Squared Inc. entered into Securities Purchase Agreement with an institutional investor valued at combined purchase price per Share and accompanying Series A Warrant and Series B Warrant of $1.00 an (effective 2023-10-23).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- an institutional investor
- Value
- combined purchase price per Share and accompanying Series A Warrant and Series B Warrant of $1.00 an
- Effective
- 2023-10-23
Exact text from the filing
On October 23, 2023, Coeptis Therapeutics Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) for the issuance and sale in a private place (the “Private Placement”) of (i) 777,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 1,223,000 shares of Common Stock, (iii) Series A warrants (the “Series A Warrants”) to purchase 2,000,000 shares of Common Stock, and (iv) Series B Warrants (the “Series B Warrants” and together with the Pre-Funded Warrants and the Series A Warrants , the “Warrants”) to purchase 2,000,000 shares of Common Stock for a combined purchase price per Share and accompanying Series A Warrant and Series B Warrant of $1.00 and a combined purchase price per Pre-Funded Warrant and accompanying Series A Warrant and Series B Warrant of $0.999.
View on SEC.gov